Beta-endorphin and male infertility

Area of Science:

• Reproductive Endocrinology
• Male Infertility Research
• Neuroendocrinology

Background:

• Beta-endorphin (beta-ED), an endogenous opiate, plays roles in various physiological processes.
• Its presence and function in the male reproductive system, particularly in relation to infertility, require further investigation.

Purpose of the Study:

• To measure beta-endorphin (beta-ED) levels in blood and seminal plasma of men with different infertility causes.
• To investigate the relationship between beta-ED and key reproductive hormones (gonadotropins, prolactin, androgens).

Main Methods:

• Blood and seminal plasma samples were collected from men with varicocele, obstructive/nonobstructive azoospermia, and idiopathic oligoasthenospermia.
• Beta-endorphin (beta-ED) levels were quantified and compared across groups.
• Serum levels of gonadotropins, prolactin, testosterone, androstenedione, and dehydroepiandrosterone sulfate were also assessed.

Main Results:

• Seminal plasma beta-endorphin (beta-ED) levels were significantly higher than blood plasma levels in all participants (p < 0.001).
• No statistically significant differences in beta-ED concentrations were found in blood or semen among the studied infertility conditions.
• No significant correlations were observed between beta-ED levels and serum gonadotropins, prolactin, or androgens.

Conclusions:

• Beta-endorphin (beta-ED) measurement in semen has limited diagnostic value for male infertility.
• The elevated levels of beta-ED in semen suggest a potential, yet unknown, function within the male reproductive tract.
• The origin of seminal beta-ED may be local to the reproductive tract, as levels did not differ between obstructive and nonobstructive azoospermia.